Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Outset Medical (OM – Research Report), Elevance Health (ELV – Research Report) and Ionis Pharmaceuticals (IONS – Research Report).
Outset Medical (OM)
In a report issued on January 9, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Outset Medical, with a price target of $31.00. The company’s shares closed last Thursday at $26.73.
According to TipRanks.com, Chadha is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Outset Medical with a $25.25 average price target.
See today’s best-performing stocks on TipRanks >>
Elevance Health (ELV)
RBC Capital analyst Ben Hendrix maintained a Hold rating on Elevance Health on January 9 and set a price target of $505.00. The company’s shares closed last Thursday at $477.08.
According to TipRanks.com, Hendrix is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Elevance Health with a $572.33 average price target.
Ionis Pharmaceuticals (IONS)
In a report issued on January 11, Luca Issi from RBC Capital maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $65.00. The company’s shares closed last Thursday at $39.03.
According to TipRanks.com, Issi has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Ionis Pharmaceuticals is a Moderate Buy with an average price target of $51.27, a 35.5% upside from current levels. In a report released yesterday, BMO Capital also maintained a Buy rating on the stock with a $70.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
